维普中文期刊产品整合服务
32篇 您的检索式:作者名="Alinari"
    题名 作者 年代 出处 被引量
1Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma显示文摘Alinari L Yu B Christian BA 2011Blood2011,117,17:1
2Gemcitabine as frontline treatment for cutaneous T-cell lymphoma:phase Ⅱ study of 32 patients显示文摘Marchi E Alinari L Tani M 2005Cancer2005,104,11:1
3FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma:is FTY720 the next autophagy-blocking agent in lymphoma treatment显示文摘Alinari L Baiocchi RA Praetorius-lbba M 0,,3:1
4Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation显示文摘Paolo Castellucci Cristina Nanni Mohsen Farsad Lapo Alinari PierLuigi Zinzani Vittorio Stefoni Giuseppe Battista Daria Valentini Cinzia Pettinato Mario Marengo Stefano Boschi Romeo Canini Michele Baccarani Nino Monetti Roberto Franchi Lucia Rampin Stefano 2005Nuclear Medicine Communications2005,,8:1
518F-FDG PET in malignant lymphoma: significance of positive findings显示文摘Paolo Castellucci PierLuigi Zinzani Michael Pourdehnad Lapo Alinari Cristina Nanni Mohsen Farsad Giuseppe Battista Monica Tani Vittorio Stefoni Romeo Canini Nino Monetti Domenico Rubello Abass Alavi Roberto Franchi Stefano Fanti 2005European Journal of Nuclear Medicine and Molecular Imaging2005,,7:1
6Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol显示文摘Alinari L Prince C J Edwards RB 2012Clin Cancer Res2012,18,17:1
7Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma显示文摘Alinari L Musuraca G Tani M 0,,10:1
8New targets of thera- py in T-cell lymphomas显示文摘ERTER J ALINARI L DARABI K 2010Curr Drug Targets2010,11,4:1
9Gemcitabine as frontline treat- ment for cutaneous T-cell lymphoma: phase Ⅲ study of 32 patients 显示文摘Marchi E Alinari L Tani M 2005Cancer2005,104,11:1
10Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma显示文摘Zinzani PL Musuraca G Alinari L 2012Clin Lymph Myeloma2012,7,4:1
11Preliminary observations of a phase Ⅱ study of reduced - dose alemtuzumab treatment in patients with pretreated T - cell lymphoma 显示文摘Zinzani PL Alinari L Tani M 2005Haematologica2005,90,5:1
12Bilateral pimary breast lymphoma:a case of local recurrence显示文摘Zinzani PL Alinari L Stefoni V 2003Leuk Lymphoma2003,44,4:1
13Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma 显示文摘Zinzani PL Musuraca G Alinari L 2007Clin Lymphoma Myeloma2007,7,4:1
14The clinical application of monoclonal antibodies in chronic lymphocytic leukemia显示文摘Jaglowski S M Alinari L Lapalombella R 2010Blood2010,116,19:1
15FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma显示文摘Liu Q Alinari L Chen CS 2010Clin Cancer Res2010,16,12:1
16Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma显示文摘Yan F Alinari L Lustberg ME 2014Cancer Res2014,74,6:1
17FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death显示文摘Alinari L Mahoney E Patton J 2011Blood2011,118,26:1
18FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: Is FrY720 the next autophagy-blocking agent in lymphoma treatment? 显示文摘Alinari L Baiocchi RA Praetorius-Ibba M 2012Autophagy2012,8,41:1
19Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma显示文摘Zinzani PL Musuraca G Alinari L 2007Clin Lymph Myeloma2007,7,4:1
20Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma 显示文摘Zinzani PL Alinari 1 Tani M 2005Haematologica2005,90,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费